Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.1800 (-8.91%) ($13.1600 - $14.4400) on Fri. Feb. 7, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.2% (three month average) | RSI | 35 | Latest Price | $13.1800(-8.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -0.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(49%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -1.6% in a week (0% probabilities). VIXM(-37%) VXX(-36%) TLT(-11%) UNG(-7%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.6% (StdDev 3.2%) | Hourly BBV | 0 () | Intraday Trend | -7.2% | | | |
|
Resistance Level | $14.59 | 5 Day Moving Average | $14.07(-6.33%) | 10 Day Moving Average | $13.87(-4.97%) | 20 Day Moving Average | $14.59(-9.66%) | To recent high | -25.9% | To recent low | 1.4% | Market Cap | $979m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |